No label defined (Q2035463)

From EU Knowledge Graph
Revision as of 01:53, 12 March 2020 by DG Regio (talk | contribs) (‎Changed an Item)
Jump to navigation Jump to search
Project in Italy financed by DG Regio
Language Label Description Also known as
English
No label defined
Project in Italy financed by DG Regio

    Statements

    country
    Italy
    0 references
    EU contribution
    186,460.21 Euro
    0 references
    budget
    372,920.43 Euro
    0 references
    co-financing rate
    49.9999986592314 percent
    0 references
    start time
    14 February 2017
    0 references
    expected end time
    13 October 2019
    0 references
    beneficiary name (string)
    EVVIVAX S.R.L.
    0 references
    ISTITUTO SUPERIORE DI SANITA'
    0 references
    beneficiary
    Q282303
    0 references
    Q275708
    0 references
    coordinate location

    41°53'35.95"N, 12°28'58.55"E
    0 references
    summary
    I VACCINI GENETICI HANNO MOLTEPLICI VANTAGGI POTENZIALI, TRA CUI IL TARGETING SPECIFICO, L'USO DI GENI MULTIPLI PER MIGLIORARE L'IMMUNITà, LA VELOCITà DI SINTESI E LA RIDUZIONE DEL RISCHIO RISPETTO AI VACCINI CONVENZIONALI. EVVIVAX Ê UNA NUOVA AZIENDA CH (Italian)
    0 references

    Identifiers

    Italian Unique Project Code
    F89J18000160007
    0 references
     
    Retrieved from "https://linkedopendata.eu/w/index.php?title=Item:Q2035463&oldid=1960373"